Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate—Danish National Register Based Cohort Study

Potential therapeutic effects of oral bisphosphonates on the intestine

(2012) Michael Pazianas et al.   Annals of the New York Academy of Sciences

Safety of bisphosphonates

(2011) Michael Pazianas et al.   BONE

Esophageal and gastric cancer incidence and mortality in alendronate users

(2011) Bo Abrahamsen et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Use of Bisphosphonates and Reduced Risk of Colorectal Cancer

(2011) Gad Rennert et al.   JOURNAL OF CLINICAL ONCOLOGY

Vitamin D and Prevention of Cancer — Ready for Prime Time?

(2011) JoAnn E. Manson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Statin Use and Colorectal Adenoma Risk: Results from the Adenoma Prevention with Celecoxib Trial

(2010) M. M. Bertagnolli et al.   Cancer Prevention Research

Evidence for a CD14+ population of monocytes in inflammatory bowel disease mucosa-implications for pathogenesis

(2010) M. C. GRIMM et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Exposure to Oral Bisphosphonates and Risk of Esophageal Cancer

(2010) Chris R. Cardwell et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of Osteoporosis Treatment on Mortality: A Meta-Analysis

(2010) Mark J. Bolland et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials

(2010) Peter M Rothwell et al.   LANCET

New Therapeutic Approaches to Mendelian Disorders

(2010) Harry C. Dietz   NEW ENGLAND JOURNAL OF MEDICINE

Oral bisphosphonates are associated with reduced mortality in frail older people: a prospective five-year study

(2010) P. N. Sambrook et al.   OSTEOPOROSIS INTERNATIONAL

Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: A meta-analysis of randomized clinical trials

(2009) Márcio Machado et al.   CLINICAL THERAPEUTICS

Activated macrophages induce metastatic behavior of colon cancer cells

(2009) Andrej Jedinak et al.   IMMUNOBIOLOGY

The bisphosphonate zoledronic acid has antimyeloma activityin vivoby inhibition of protein prenylation

(2009) Andreas Guenther et al.   INTERNATIONAL JOURNAL OF CANCER

Potential mediators of the mortality reduction with zoledronic acid after hip fracture

(2009) Cathleen S Colón-Emeric et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo

(2009) Anke J Roelofs et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Efficient Killing of Human Colon Cancer Stem Cells by    T Lymphocytes

(2009) M. Todaro et al.   JOURNAL OF IMMUNOLOGY

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

(2009) Jack Cuzick et al.   LANCET ONCOLOGY

More on Reports of Esophageal Cancer with Oral Bisphosphonate Use

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

The bisphosphonate zoledronic acid inhibits the growth of HCT-116 colon carcinoma cells and induces tumor cell apoptosis

(2008) Lilian Sewing et al.   APOPTOSIS

Peripheral blood monocytes are responsible for γδ T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP

(2008) Anke J. Roelofs et al.   BRITISH JOURNAL OF HAEMATOLOGY

Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging

(2008) Ignacio Varela et al.   NATURE MEDICINE

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy

(2008) R. G. G. Russell et al.   OSTEOPOROSIS INTERNATIONAL